Purchase Short-Term Access
Anti–tumor necrosis factor therapy was not associated with greater risk for mortality than standard therapy in rheumatoid arthritis
Ami Schattner, MD
Annals of Internal Medicine 2011;154:JC3-13.
doi:10.7326/0003-4819-154-6-201103150-02013
Purchase Online access to this article for 24 hours
